People_

Dr Venu Chalasani

Urological Surgeon, Clinical Senior Lecturer
Surgery, Northern Clinical School

Phone

+61 2 9439 1301

Fax

+61 2 9439 2607

Themes

Cancer

Keywords

Surgery, Urology, Testis, Kidney, Bladder

Approaches

Adult, Surgery, Treatment/Intervention

Clinical speciality

Surgery

Publications

By Type

Expand all

Book Chapters

Chalasani, V., Izawa, J. (2009). Surgical Anatomy of the Pelvis. In Stephen W Leslie (Eds.), Urology Review Board Pearls of Wisdom, (pp. 61-73). United States of America: McGraw-Hill. United States.

Journals

Pattenden, T., Rashid, P., Winter, M., Vela, I., Pryor, D., Mark, S., Loeb, S., Lawrentschuk, N., Pritchard, E., Thangasamy, I., Chalasani, V., et al (2024). Barriers and enablers of active surveillance for prostate cancer: a qualitive study of clinicians. BJU International, 133(Suppl 3), 48-56. [More Information]
Guo, A., Zeng, K., Bushati, Y., Kim, P., Zhong, W., Chalasani, V., Winter, M. (2024). Cardiopulmonary exercise testing prior to radical cystectomy: a systematic review and meta-analysis. BJU International. [More Information]
Jain, A., Woo, H., Nassour, A., Khannani, H., Wines, M., Chalasani, V., Katelaris, P., Bergersen, P., Symons, J., Baskaranathan, S. (2023). Australian surgical revision rate for benign prostatic obstruction. BJU International, 131(S4), 43-47. [More Information]
Pattenden, T., Samaranayke, D., Morton, A., Ong, W., Murphy, D., Pritchard, E., Evans, S., Millar, J., Chalasani, V., Rashid, P., et al (2023). Modern Active Surveillance in Prostate Cancer: A Narrative Review. Clinical Genitourinary Cancer, 21(1), 115-123. [More Information]
Woo, H., Khanani, H., Thompson, N., Sorensen, B., Baskaranathan, S., Bergersen, P., Chalasani, V., Dean, T., Dias, M., Symons, J., et al (2023). Multiparametric Magnetic Resonance Imaging of the Prostate and Prostate-specific Membrane Positron Emission Tomography Prior to Prostate Biopsy (MP4 Study). European Urology Open Science, 47, 119-125. [More Information]
Ong, W., Thangasamy, I., Murphy, D., Pritchard, E., Evans, S., Millar, J., Chalasani, V., Rashid, P., Winter, M., Vela, I., et al (2022). Large variation in conservative management of low-risk prostate cancer in Australia and New Zealand. BJU International, 130(Suppl 1), 17-19. [More Information]
Hayne, D., Grummet, J., Espinoza, D., McCombie, S., Chalasani, V., Ford, K., Frydenberg, M., Gilling, P., Gordon, B., Hawks, C., Patel, M., et al (2021). 'Pain-free TRUS B': a phase 3 double-blind placebo-controlled randomized trial of methoxyflurane with periprostatic local anaesthesia to reduce the discomfort of transrectal ultrasonography-guided prostate biopsy (ANZUP 1501). BJU International. [More Information]
Parkin, C., Wilcox, C., Chalasani, V. (2021). A rare case of an enormous sacral meningocele causing ureteric obstruction. Urology Case Reports, 38, 101703. [More Information]
Hanna, B., Zhuo, K., Chalasani, V., Vass, J., Rasiah, K., Wines, M., Vaux, K., Chung, A. (2021). Association between ureteric stent dwell time and urinary tract infection. ANZ Journal of Surgery, 91, 187-191. [More Information]
Hanna, B., White, J., Chalasani, V., McGinn, S., Winter, M. (2021). Double partial nephrectomy in allograft transplanted kidney. Urology Case Reports, 35, 101517. [More Information]
Vargas, A., Burchett, I., Turner, J., Delprado, W., Chalasani, V., Gill, A., Maclean, F. (2021). Monotypic Plasma Cell Proliferation of Uncertain Clinical Significance Mimicking Interstitial Cystitis: An Early Lesion of MALT Lymphoma? The American Journal of Surgical Pathology, 45(6), 841-853. [More Information]
Emmett, L., Buteau, J., Papa, N., Moon, D., Thompson, J., Roberts, M., Rasiah, K., Pattison, D., Yaxley, J., Thomas, P., et al (2021). The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study[Formula presented]. European Urology, 80(6), 682-689. [More Information]
Hanna, B., McNaught, A., Chung, A., Chalasani, V. (2020). Ectopic prostatic tissue in the perineum. BMJ Case Reports, 13(11), e239378. [More Information]
Amin, A., Blazevski, A., Thompson, J., Scheltema, M., Hofman, M., Murphy, D., Lawrentschuk, N., Sathianathen, N., Kapoor, J., Woo, H., Chalasani, V., et al (2020). Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross-sectional study of the additive diagnostic value of gallium-68 prostate-specific membrane antigen positron-emission tomography/computed tomography to multiparametric magnetic resonance imaging in the diagnostic setting for men being investigated for prostate cancer. BJU International, 125(4), 515-524. [More Information]
Eade, T., Hruby, G., Booth, J., Bromley, R., Guo, L., O'Toole, A., Le, A., Wu, K., Rasiah, K., Chalasani, V., Kneebone, A., et al (2019). Results of a Prospective Dose Escalation Study of Linear Accelerator - Based Virtual Brachytherapy (BOOSTER) for Prostate Cancer; Virtual HDR Brachytherapy for Prostate Cancer. Advances in Radiation Oncology, 4(4), 623-630. [More Information]
Cole-Clark, D., Nair-Shalliker, V., Bang, A., Rasiah, K., Chalasani, V., Smith, D. (2018). An initial melanoma diagnosis may increase the subsequent risk of prostate cancer: Results from the New South Wales Cancer Registry. Scientific Reports, 8(1), 1-7. [More Information]
Wallis, C., Cheung, D., Klotz, L., Chalasani, V., Leao, R., Garisto, J., Morton, G., Nam, R., Tannock, I., Satkunasivam, R. (2018). Personal prostate-specific antigen screening and treatment choices for localized prostate cancer among expert physicians. Canadian Urological Association Journal, 12(2), E59-E63. [More Information]
Calopedos, R., Chalasani, V., Asher, R., Emmett, L., Woo, H. (2017). Lutetium-177-labelled anti-prostate-specific membrane antigen antibody and ligands for the treatment of metastatic castrate-resistant prostate cancer: A systematic review and meta-analysis. Prostate Cancer and Prostatic Diseases, 20(3), 352-360. [More Information]
Knapp, G., Chalasani, V., Woo, H. (2017). Perioperative adverse events in patients on continued anticoagulation undergoing photoselective vaporisation of the prostate with the 180-W Greenlight lithium triborate laser. BJU International, 119, 33-38. [More Information]
Cole-Clark, A., Cole-Clark, D., Winter, M., Chalasani, V., Bergersen, P. (2017). Retro-ureteral Small Bowel Herniation After Radical Cystectomy. Urology Case Reports, 15, 1-2. [More Information]
Kam, J., Tsang, V., Chalasani, V. (2017). Retrograde Ejaculation: A Rare Presenting Symptom of Type 1 Diabetes Mellitus. Urology Case Reports, 10, 9-10. [More Information]
Garcia, C., Jina, H., Bergersen, P., Chalasani, V. (2016). Bladder Contracture - A Rare and Serious Side Effect of Intravesical Bacillus Calmette-Guérin Therapy. Urology Case Reports, 4, 22-24. [More Information]
Gunaratne, D., Krieger, L., Maclean, F., Vaux, K., Chalasani, V. (2016). Neoadjuvant Chemotherapy With Gemcitabine and Cisplatin for Plasmacytoid Urothelial Bladder Cancer: A Case Report and Review of the Literature. Clinical Genitourinary Cancer, 14(1), e103-e105. [More Information]
Feletto, E., Bang, A., Cole-Clark, D., Chalasani, V., Rasiah, K., Smith, D. (2015). An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high? World Journal of Urology, 33(11), 1677-1687. [More Information]
Hayne, D., Stockler, M., McCombie, S., Chalasani, V., Long, A., Martin, A., Sengupta, S., Davis, I. (2015). BCG+MMC trial: adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: a randomised phase III trial (ANZUP 1301). BMC Cancer, 15(1), 1-7. [More Information]
Yoon, P., Chalasani, V., Woo, H. (2015). Systematic review and meta-analysis on management of acute urinary retention. Prostate Cancer and Prostatic Diseases, 18(4), 297-302. [More Information]
Bhatia, D., Winter, M., Dias, M., Chalasani, V. (2014). Bladder scanner pitfalls: beware ovarian cysts. British Journal of Hospital Medicine, 75(4), 232-233. [More Information]
Nalavenkata, S., Winter, M., Pickett, J., Dias, M., Chalasani, V. (2014). Fibrous Pseudotumor of the Penis - An Unusual Finding During Repair of Fractured Penis. Urology Case Reports, 2(1), 13-15. [More Information]
Palmer, T., Martínez, C., Vasquez, C., Hebron, K., Jones-Paris, C., Arnold, S., Chan, S., Chalasani, V., Gomez-Lemus, J., Williams, A., et al (2014). Integrin-free tetraspanin CD151 can inhibit tumor cell motility upon clustering and is a clinical indicator of prostate cancer progression. Cancer Research, 74(1), 173-187. [More Information]
Garcia, C., Winter, M., Chalasani, V., Dean, T. (2014). Penile Abscess: A Case Report and Review of Literature. Urology Case Reports, 2, 17-19. [More Information]
Houghton, B., Chalasani, V., Hayne, D., Grimison, P., Brown, C., Patel, M., Davis, I., Stockler, M. (2013). Intravesical chemotherapy plus bacille Calmette-Guerin in non-muscle invasive bladder cancer: a systematic review with meta-analysis. BJU International, 111(6), 977-933. [More Information]
Woo, H., Thangasamy, I., Chalasani, V. (2013). Photoselective vaporization with the green light laser vs transurethral resection of the prostate for treating benign prostate hyperplasia: a systematic review and meta-analysis. BJU International, 111(4), E137. [More Information]
Yoon, P., Chalasani, V., Woo, H. (2013). Use of Clavien-Dindo Classiï¬�cation in Reporting and Grading Complications after Urological Surgical Procedures: Analysis of 2010 to 2012. The Journal of Urology, 190(4), 1271-1274. [More Information]
Yoon, P., Chalasani, V., Woo, H. (2012). Conversion rates of abstracts presented at the Urological Society of Australia and New Zealand (USANZ) Annual Scientific Meeting into full-text journal articles. BJU International, 110(4), 485-489. [More Information]
Thangasamy, I., Chalasani, V., Bachmann, A., Woo, H. (2012). Photoselective Vaporisation of the Prostate Using 80-W and 120-W Laser Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: A Systematic Review with Meta-Analysis from 2002 to 2012. European Urology, 62(2), 315-323. [More Information]
Ahmed, H., Cathcart, P., Chalasani, V., Williams, A., McCartan, N., Freeman, A., Kirkham, A., Allen, C., Chin, J., Emberton, M. (2012). Whole-Gland Salvage High-Intensity Focused Ultrasound Therapy for Localized Prostate Cancer Recurrence After External Beam Radiation Therapy. Cancer, 118(12), 3071-3078. [More Information]
Williams, A., Chalasani, V., MartÃnez, C., Osbourne, E., Stitt, L., Izawa, J., Pautler, S. (2011). Cumulative summation graphs are a useful tool for monitoring positive surgical margin rates in robot-assisted radical prostatectomy. BJU International, 107(10), 1648-1652. [More Information]
Lu, C., Williams, A., Chalasani, V., Martinez, C., Chin, J. (2011). Immunotherapy for metastatic prostate cancer: where are we at with sipuleucel-T? Expert Opinion on Biological Therapy, 11(1), 99-108. [More Information]
Chalasani, V., Williams, A., Chin, J. (2010). Contemporary results of focal therapy for prostate cancer using cryotherapy. Panminerva Medica, 52(3), 217-222. [More Information]
Dion, M., Martinez, C., Williams, A., Chalasani, V., Nott, L., Pautler, S. (2010). Cost analysis of two follow-up strategies for localized kidney cancer: a Canadian cohort comparison. Canadian Urological Association Journal, 4(5), 322-326. [More Information]
Martinez, C., Chalasani, V., Lim, D., Nott, L., Al-Bareeq, R., Wignall, G., Stitt, L., Pautler, S. (2010). Effect of prostate gland size on the learning curve for robot-assisted laparoscopic radical prostatectomy: does size matter initially? Journal of Endourology, 24(2), 261-266. [More Information]
Chalasani, V., Martinez, C., Lim, D., Al-Bareeq, R., Wignall, G., Stitt, L., Pautler, S. (2010). Impact of body mass index on perioperative outcomes during the learning curve for robot-assisted radical prostatectomy. Canadian Urological Association Journal, 4(4), 250-254. [More Information]
Chalasani, V., Bissoon, D., Bhuvanagiri, A., Mizzi, A., Dunn, I. (2010). Should PCNL patients have a CT in the prone position preoperatively? Canadian Journal of Urology, 17(2), 5082-5086. [More Information]
Chalasani, V., Martinez, C., Lim, D., Abdelhady, M., Chin, J. (2010). Surgical cryoablation as an option for small renal masses in patients who are not ideal partial nephrectomy candidates: intermediate-term outcomes. Canadian Urological Association Journal, 4(6), 399-402. [More Information]
Chalasani, V., Macek, P., O'Neill, G., Barret, W. (2010). Ureteric stricture secondary to unusual extension of prostatic adenocarcinoma. Canadian Journal of Urology, 17(1), 5031-5034. [More Information]
Chalasani, V., Chin, J., Izawa, J. (2009). Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer. Canadian Urological Association Journal, 3(6 Suppl 4), S193-S138. [More Information]
Martinez, C., Chalasani, V., Chin, J. (2009). Molecular biomarkers in prostate cancer. Expert Opinion on Medical Diagnostics, 3(4), 345-353.
Chalasani, V., Abdelhady, M., Stitt, L., Izawa, J. (2009). Quality assurance and benchmarking for radical cystectomy: monitoring early complications and mortality using cumulative summation charts. The Journal of Urology, 181(4), 1581-1586. [More Information]
Chalasani, V., Martinez, C., Lim, D., Chin, J. (2009). Salvage HIFU for recurrent prostate cancer after radiotherapy. Prostate Cancer and Prostatic Diseases, 12(2), 124-129. [More Information]
Eslick, G., Chalasani, V., Salama, A. (2006). Idiopathic pneumoperitoneum. European journal of internal medicine, 17(2), 141-3. [More Information]

show 47 more

By Year

Expand all

2024

Pattenden, T., Rashid, P., Winter, M., Vela, I., Pryor, D., Mark, S., Loeb, S., Lawrentschuk, N., Pritchard, E., Thangasamy, I., Chalasani, V., et al (2024). Barriers and enablers of active surveillance for prostate cancer: a qualitive study of clinicians. BJU International, 133(Suppl 3), 48-56. [More Information]
Guo, A., Zeng, K., Bushati, Y., Kim, P., Zhong, W., Chalasani, V., Winter, M. (2024). Cardiopulmonary exercise testing prior to radical cystectomy: a systematic review and meta-analysis. BJU International. [More Information]

2023

Jain, A., Woo, H., Nassour, A., Khannani, H., Wines, M., Chalasani, V., Katelaris, P., Bergersen, P., Symons, J., Baskaranathan, S. (2023). Australian surgical revision rate for benign prostatic obstruction. BJU International, 131(S4), 43-47. [More Information]
Pattenden, T., Samaranayke, D., Morton, A., Ong, W., Murphy, D., Pritchard, E., Evans, S., Millar, J., Chalasani, V., Rashid, P., et al (2023). Modern Active Surveillance in Prostate Cancer: A Narrative Review. Clinical Genitourinary Cancer, 21(1), 115-123. [More Information]
Woo, H., Khanani, H., Thompson, N., Sorensen, B., Baskaranathan, S., Bergersen, P., Chalasani, V., Dean, T., Dias, M., Symons, J., et al (2023). Multiparametric Magnetic Resonance Imaging of the Prostate and Prostate-specific Membrane Positron Emission Tomography Prior to Prostate Biopsy (MP4 Study). European Urology Open Science, 47, 119-125. [More Information]

2022

Ong, W., Thangasamy, I., Murphy, D., Pritchard, E., Evans, S., Millar, J., Chalasani, V., Rashid, P., Winter, M., Vela, I., et al (2022). Large variation in conservative management of low-risk prostate cancer in Australia and New Zealand. BJU International, 130(Suppl 1), 17-19. [More Information]

2021

Hayne, D., Grummet, J., Espinoza, D., McCombie, S., Chalasani, V., Ford, K., Frydenberg, M., Gilling, P., Gordon, B., Hawks, C., Patel, M., et al (2021). 'Pain-free TRUS B': a phase 3 double-blind placebo-controlled randomized trial of methoxyflurane with periprostatic local anaesthesia to reduce the discomfort of transrectal ultrasonography-guided prostate biopsy (ANZUP 1501). BJU International. [More Information]
Parkin, C., Wilcox, C., Chalasani, V. (2021). A rare case of an enormous sacral meningocele causing ureteric obstruction. Urology Case Reports, 38, 101703. [More Information]
Hanna, B., Zhuo, K., Chalasani, V., Vass, J., Rasiah, K., Wines, M., Vaux, K., Chung, A. (2021). Association between ureteric stent dwell time and urinary tract infection. ANZ Journal of Surgery, 91, 187-191. [More Information]
Hanna, B., White, J., Chalasani, V., McGinn, S., Winter, M. (2021). Double partial nephrectomy in allograft transplanted kidney. Urology Case Reports, 35, 101517. [More Information]
Vargas, A., Burchett, I., Turner, J., Delprado, W., Chalasani, V., Gill, A., Maclean, F. (2021). Monotypic Plasma Cell Proliferation of Uncertain Clinical Significance Mimicking Interstitial Cystitis: An Early Lesion of MALT Lymphoma? The American Journal of Surgical Pathology, 45(6), 841-853. [More Information]
Emmett, L., Buteau, J., Papa, N., Moon, D., Thompson, J., Roberts, M., Rasiah, K., Pattison, D., Yaxley, J., Thomas, P., et al (2021). The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study[Formula presented]. European Urology, 80(6), 682-689. [More Information]

show 3 more

2020

Hanna, B., McNaught, A., Chung, A., Chalasani, V. (2020). Ectopic prostatic tissue in the perineum. BMJ Case Reports, 13(11), e239378. [More Information]
Amin, A., Blazevski, A., Thompson, J., Scheltema, M., Hofman, M., Murphy, D., Lawrentschuk, N., Sathianathen, N., Kapoor, J., Woo, H., Chalasani, V., et al (2020). Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross-sectional study of the additive diagnostic value of gallium-68 prostate-specific membrane antigen positron-emission tomography/computed tomography to multiparametric magnetic resonance imaging in the diagnostic setting for men being investigated for prostate cancer. BJU International, 125(4), 515-524. [More Information]

2019

Eade, T., Hruby, G., Booth, J., Bromley, R., Guo, L., O'Toole, A., Le, A., Wu, K., Rasiah, K., Chalasani, V., Kneebone, A., et al (2019). Results of a Prospective Dose Escalation Study of Linear Accelerator - Based Virtual Brachytherapy (BOOSTER) for Prostate Cancer; Virtual HDR Brachytherapy for Prostate Cancer. Advances in Radiation Oncology, 4(4), 623-630. [More Information]

2018

Cole-Clark, D., Nair-Shalliker, V., Bang, A., Rasiah, K., Chalasani, V., Smith, D. (2018). An initial melanoma diagnosis may increase the subsequent risk of prostate cancer: Results from the New South Wales Cancer Registry. Scientific Reports, 8(1), 1-7. [More Information]
Wallis, C., Cheung, D., Klotz, L., Chalasani, V., Leao, R., Garisto, J., Morton, G., Nam, R., Tannock, I., Satkunasivam, R. (2018). Personal prostate-specific antigen screening and treatment choices for localized prostate cancer among expert physicians. Canadian Urological Association Journal, 12(2), E59-E63. [More Information]

2017

Calopedos, R., Chalasani, V., Asher, R., Emmett, L., Woo, H. (2017). Lutetium-177-labelled anti-prostate-specific membrane antigen antibody and ligands for the treatment of metastatic castrate-resistant prostate cancer: A systematic review and meta-analysis. Prostate Cancer and Prostatic Diseases, 20(3), 352-360. [More Information]
Knapp, G., Chalasani, V., Woo, H. (2017). Perioperative adverse events in patients on continued anticoagulation undergoing photoselective vaporisation of the prostate with the 180-W Greenlight lithium triborate laser. BJU International, 119, 33-38. [More Information]
Cole-Clark, A., Cole-Clark, D., Winter, M., Chalasani, V., Bergersen, P. (2017). Retro-ureteral Small Bowel Herniation After Radical Cystectomy. Urology Case Reports, 15, 1-2. [More Information]
Kam, J., Tsang, V., Chalasani, V. (2017). Retrograde Ejaculation: A Rare Presenting Symptom of Type 1 Diabetes Mellitus. Urology Case Reports, 10, 9-10. [More Information]

show 1 more

2016

Garcia, C., Jina, H., Bergersen, P., Chalasani, V. (2016). Bladder Contracture - A Rare and Serious Side Effect of Intravesical Bacillus Calmette-Guérin Therapy. Urology Case Reports, 4, 22-24. [More Information]
Gunaratne, D., Krieger, L., Maclean, F., Vaux, K., Chalasani, V. (2016). Neoadjuvant Chemotherapy With Gemcitabine and Cisplatin for Plasmacytoid Urothelial Bladder Cancer: A Case Report and Review of the Literature. Clinical Genitourinary Cancer, 14(1), e103-e105. [More Information]

2015

Feletto, E., Bang, A., Cole-Clark, D., Chalasani, V., Rasiah, K., Smith, D. (2015). An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high? World Journal of Urology, 33(11), 1677-1687. [More Information]
Hayne, D., Stockler, M., McCombie, S., Chalasani, V., Long, A., Martin, A., Sengupta, S., Davis, I. (2015). BCG+MMC trial: adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: a randomised phase III trial (ANZUP 1301). BMC Cancer, 15(1), 1-7. [More Information]
Yoon, P., Chalasani, V., Woo, H. (2015). Systematic review and meta-analysis on management of acute urinary retention. Prostate Cancer and Prostatic Diseases, 18(4), 297-302. [More Information]

2014

Bhatia, D., Winter, M., Dias, M., Chalasani, V. (2014). Bladder scanner pitfalls: beware ovarian cysts. British Journal of Hospital Medicine, 75(4), 232-233. [More Information]
Nalavenkata, S., Winter, M., Pickett, J., Dias, M., Chalasani, V. (2014). Fibrous Pseudotumor of the Penis - An Unusual Finding During Repair of Fractured Penis. Urology Case Reports, 2(1), 13-15. [More Information]
Palmer, T., Martínez, C., Vasquez, C., Hebron, K., Jones-Paris, C., Arnold, S., Chan, S., Chalasani, V., Gomez-Lemus, J., Williams, A., et al (2014). Integrin-free tetraspanin CD151 can inhibit tumor cell motility upon clustering and is a clinical indicator of prostate cancer progression. Cancer Research, 74(1), 173-187. [More Information]
Garcia, C., Winter, M., Chalasani, V., Dean, T. (2014). Penile Abscess: A Case Report and Review of Literature. Urology Case Reports, 2, 17-19. [More Information]

show 1 more

2013

Houghton, B., Chalasani, V., Hayne, D., Grimison, P., Brown, C., Patel, M., Davis, I., Stockler, M. (2013). Intravesical chemotherapy plus bacille Calmette-Guerin in non-muscle invasive bladder cancer: a systematic review with meta-analysis. BJU International, 111(6), 977-933. [More Information]
Woo, H., Thangasamy, I., Chalasani, V. (2013). Photoselective vaporization with the green light laser vs transurethral resection of the prostate for treating benign prostate hyperplasia: a systematic review and meta-analysis. BJU International, 111(4), E137. [More Information]
Yoon, P., Chalasani, V., Woo, H. (2013). Use of Clavien-Dindo Classiï¬�cation in Reporting and Grading Complications after Urological Surgical Procedures: Analysis of 2010 to 2012. The Journal of Urology, 190(4), 1271-1274. [More Information]

2012

Yoon, P., Chalasani, V., Woo, H. (2012). Conversion rates of abstracts presented at the Urological Society of Australia and New Zealand (USANZ) Annual Scientific Meeting into full-text journal articles. BJU International, 110(4), 485-489. [More Information]
Thangasamy, I., Chalasani, V., Bachmann, A., Woo, H. (2012). Photoselective Vaporisation of the Prostate Using 80-W and 120-W Laser Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: A Systematic Review with Meta-Analysis from 2002 to 2012. European Urology, 62(2), 315-323. [More Information]
Ahmed, H., Cathcart, P., Chalasani, V., Williams, A., McCartan, N., Freeman, A., Kirkham, A., Allen, C., Chin, J., Emberton, M. (2012). Whole-Gland Salvage High-Intensity Focused Ultrasound Therapy for Localized Prostate Cancer Recurrence After External Beam Radiation Therapy. Cancer, 118(12), 3071-3078. [More Information]

2011

Williams, A., Chalasani, V., MartÃnez, C., Osbourne, E., Stitt, L., Izawa, J., Pautler, S. (2011). Cumulative summation graphs are a useful tool for monitoring positive surgical margin rates in robot-assisted radical prostatectomy. BJU International, 107(10), 1648-1652. [More Information]
Lu, C., Williams, A., Chalasani, V., Martinez, C., Chin, J. (2011). Immunotherapy for metastatic prostate cancer: where are we at with sipuleucel-T? Expert Opinion on Biological Therapy, 11(1), 99-108. [More Information]

2010

Chalasani, V., Williams, A., Chin, J. (2010). Contemporary results of focal therapy for prostate cancer using cryotherapy. Panminerva Medica, 52(3), 217-222. [More Information]
Dion, M., Martinez, C., Williams, A., Chalasani, V., Nott, L., Pautler, S. (2010). Cost analysis of two follow-up strategies for localized kidney cancer: a Canadian cohort comparison. Canadian Urological Association Journal, 4(5), 322-326. [More Information]
Martinez, C., Chalasani, V., Lim, D., Nott, L., Al-Bareeq, R., Wignall, G., Stitt, L., Pautler, S. (2010). Effect of prostate gland size on the learning curve for robot-assisted laparoscopic radical prostatectomy: does size matter initially? Journal of Endourology, 24(2), 261-266. [More Information]
Chalasani, V., Martinez, C., Lim, D., Al-Bareeq, R., Wignall, G., Stitt, L., Pautler, S. (2010). Impact of body mass index on perioperative outcomes during the learning curve for robot-assisted radical prostatectomy. Canadian Urological Association Journal, 4(4), 250-254. [More Information]
Chalasani, V., Bissoon, D., Bhuvanagiri, A., Mizzi, A., Dunn, I. (2010). Should PCNL patients have a CT in the prone position preoperatively? Canadian Journal of Urology, 17(2), 5082-5086. [More Information]
Chalasani, V., Martinez, C., Lim, D., Abdelhady, M., Chin, J. (2010). Surgical cryoablation as an option for small renal masses in patients who are not ideal partial nephrectomy candidates: intermediate-term outcomes. Canadian Urological Association Journal, 4(6), 399-402. [More Information]
Chalasani, V., Macek, P., O'Neill, G., Barret, W. (2010). Ureteric stricture secondary to unusual extension of prostatic adenocarcinoma. Canadian Journal of Urology, 17(1), 5031-5034. [More Information]

show 4 more

2009

Chalasani, V., Chin, J., Izawa, J. (2009). Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer. Canadian Urological Association Journal, 3(6 Suppl 4), S193-S138. [More Information]
Martinez, C., Chalasani, V., Chin, J. (2009). Molecular biomarkers in prostate cancer. Expert Opinion on Medical Diagnostics, 3(4), 345-353.
Chalasani, V., Abdelhady, M., Stitt, L., Izawa, J. (2009). Quality assurance and benchmarking for radical cystectomy: monitoring early complications and mortality using cumulative summation charts. The Journal of Urology, 181(4), 1581-1586. [More Information]
Chalasani, V., Martinez, C., Lim, D., Chin, J. (2009). Salvage HIFU for recurrent prostate cancer after radiotherapy. Prostate Cancer and Prostatic Diseases, 12(2), 124-129. [More Information]
Chalasani, V., Izawa, J. (2009). Surgical Anatomy of the Pelvis. In Stephen W Leslie (Eds.), Urology Review Board Pearls of Wisdom, (pp. 61-73). United States of America: McGraw-Hill. United States.

show 2 more

2006

Eslick, G., Chalasani, V., Salama, A. (2006). Idiopathic pneumoperitoneum. European journal of internal medicine, 17(2), 141-3. [More Information]

Selected Grants

2015

Pain Free TRUS B: A placebo-controlled, randomised trial of methoxyflurane to reduce the discomfort of prostate biopsy, Davis I, Grummet J, Chalasani V, Stockler M, Martin A, Hayne D, Woo H, Frydenberg M, O'Brien C, Buchan N, Cancer Australia/Priority Driven Collaborative Cancer Research Scheme

2013

Adding mitomycin C to intravesical BCG for high-risk, non-muscle-invasive bladder cancer: a randomised phase 3 trial, Hayne D, Patel M, Stockler M, Sengupta S, Frydenberg M, Chalasani V, Gebski V, Davis I, Cancer Australia/Priority Driven Collaborative Cancer Research Scheme

Faculty of Medicine and Health